Compare MLTX & PGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MLTX | PGY |
|---|---|---|
| Founded | 2021 | 2016 |
| Country | Switzerland | United States |
| Employees | N/A | 511 |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | 2020 | N/A |
| Metric | MLTX | PGY |
|---|---|---|
| Price | $18.95 | $15.65 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 8 |
| Target Price | $27.50 | ★ $34.50 |
| AVG Volume (30 Days) | 900.0K | ★ 3.8M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $14.27 |
| Revenue Next Year | N/A | $14.39 |
| P/E Ratio | ★ N/A | $13.54 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.95 | $10.40 |
| 52 Week High | $62.75 | $44.99 |
| Indicator | MLTX | PGY |
|---|---|---|
| Relative Strength Index (RSI) | 58.86 | 64.91 |
| Support Level | $15.54 | $10.78 |
| Resistance Level | $19.16 | $17.14 |
| Average True Range (ATR) | 0.91 | 0.87 |
| MACD | 0.17 | 0.16 |
| Stochastic Oscillator | 84.64 | 92.97 |
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.
Pagaya Technologies Ltd is a product-focused technology company. It uses machine learning, a vast data network, and an AI-driven approach to offer comprehensive consumer credit and residential real estate products for its partners, their customers, and investors. Its suite of products includes Decline Monetization, Dual Look, First Look, Affiliate Optimizer Engine, Direct Marketing Engine, and FastPass, providing lenders with an AI-powered credit and acquisition ecosystem that helps them approve more borrowers, capture more demand, and grow without adding risk. Geographically, the company generates maximum revenue from its business in the United States.